Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
European Journal of Gastroenterology & Hepatology|December 7, 2002
Irritable bowel syndrome in Germany. A cost of illness studyStefan A Müller-Lissner, Olaf PirkExpert Opinion on Pharmacotherapy|July 16, 2009
The value of irbesartan in the management of hypertensionPeter Bramlage, Isabelle Durand-Zaleski, Nisha Desai, et al.Health Policy (Amsterdam, Netherlands)|March 7, 2002
Diffusion of innovations: treatment of Alzheimer's disease in GermanyJörg Ruof, Thomas Mittendorf, Olaf Pirk, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 22, 2015
The Suitability of End Point Designs for Health Technology Assessment in Chronic Pain StudiesCatherine E Rycroft, Matthew Hirst, William C N Dunlop, et al.Pharmacoeconomics|July 6, 2016
BEACON: A Summary Framework to Overcome Potential Reimbursement HurdlesWilliam C N Dunlop, C Daniel Mullins, Olaf Pirk, et al.BMC Health Services Research|June 9, 2009
Dementia care initiative in primary practice: study protocol of a cluster randomized trial on dementia management in a general practice settingRolf Holle, Elmar Grässel, Stefan Ruckdäschel, et al.Pageof 1